HD

Hiren Dasharathbhai Patel

Active Director Director DIN 03560495
DIN 03560495 First appointment Mar 2012 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Past companies 1 historical roles
Total affiliations 4 Since Mar 2012
Shareholding value •••• Premium profile

About Hiren Dasharathbhai Patel

Data last updated:

Hiren Dasharathbhai Patel is a Director at Orbicular Pharmaceutical Technologies Private Limited (since 2012), Director at Invitron Advanced Analytics Private Limited (since 2016) and Director at Orus Life Sciences Private Limited (since 2012). The companies operate in Pharma and Chemicals and Materials. The 3 current companies with reported revenue have a combined latest revenue of ₹315 Cr; the largest is Orbicular Pharmaceutical Technologies Private Limited at ₹272 Cr (FY 2025). Earlier, Hiren Dasharathbhai Patel was a Director at Aleor Dermaceuticals Limited (2016–2020).

DIN 03560495
Primary Designation Director
Industry Pharma
First Appointment 05 Mar 2012
Oldest Company Age 18 yrs
Largest company Orbicular Pharmaceutical Technologies Private Limited · ₹272 Cr (FY 2025)
Combined revenue ₹315 Cr across 3 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director24 Aug 20122008₹272 Cr (FY 2025)Active
Director17 Dec 20162013₹43.23 Cr (FY 2025)Active
Orus Life Sciences Private Limited U24100TG2012PTC079507
Director05 Mar 20122012₹5,653 (FY 2025)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Aleor Dermaceuticals Limited U24302GJ2016PLC092131
Director23 May 20162016₹16.23 Cr (FY 2021)Amalgamated

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Orus Life Sciences Private Limited
Orbicular Pharmaceutical Technologies Private Limited
Invitron Advanced Analytics Private Limited
Aleor Dermaceuticals Limited
Premium access

Shareholding and investment profile for Hiren Dasharathbhai Patel

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Hiren Dasharathbhai Patel

Hiren Dasharathbhai Patel currently holds 3 directorships: Orbicular Pharmaceutical Technologies Private Limited (Director, since 24 Aug 2012, revenue ₹272 Cr (FY 2025)); Invitron Advanced Analytics Private Limited (Director, since 17 Dec 2016, revenue ₹43.23 Cr (FY 2025)); Orus Life Sciences Private Limited (Director, since 05 Mar 2012, revenue ₹5,653 (FY 2025)).

Hiren Dasharathbhai Patel was first appointed on 05 Mar 2012 as Director at Orus Life Sciences Private Limited. The most recent appointment on record is 17 Dec 2016 at Invitron Advanced Analytics Private Limited.

The 3 current companies of Hiren Dasharathbhai Patel that report revenue have a combined latest revenue of ₹315 Cr: Orbicular Pharmaceutical Technologies Private Limited ₹272 Cr (FY 2025); Invitron Advanced Analytics Private Limited ₹43.23 Cr (FY 2025); Orus Life Sciences Private Limited ₹5,653 (FY 2025).

Hiren Dasharathbhai Patel held 1 earlier board appointment: Aleor Dermaceuticals Limited (Director, 23 May 2016 to 20 Oct 2020).

The current boards of Hiren Dasharathbhai Patel's companies include Balaji Boggarapu (Orbicular Pharmaceutical Technologies Private Limited), Bhaveshkumar Vallabhbhai Patel (Orbicular Pharmaceutical Technologies Private Limited), Meena Mohan (Orbicular Pharmaceutical Technologies Private Limited), Rahul Gawande Sudhakar (Orbicular Pharmaceutical Technologies Private Limited), Sivaraman Mohan Mailatur (Orbicular Pharmaceutical Technologies Private Limited), Visalakshi Chandramouli (Orbicular Pharmaceutical Technologies Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available